{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:04:00Z","timestamp":1762113840767,"version":"3.44.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bulcan.2020.04.015","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T17:24:14Z","timestamp":1591982654000},"page":"S159-S169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Importance des anticorps dans la prise en charge de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: anticorps anti-HLA, anti-plaquettes, anti-granuleux, anti-\u00e9rythrocytes et anti-MICA. Recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-0698","authenticated-orcid":false,"given":"Florent","family":"Delbos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Crocchiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Desoutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Detrait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khan Tien","family":"Nguyen-Lejarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Giannoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Lemari\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Renac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11S","key":"10.1016\/j.bulcan.2020.04.015_bib0375","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0380","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.patbio.2014.05.007","article-title":"Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC","volume":"62","author":"Loiseau","year":"2014","journal-title":"Pathol Biol (Paris)"},{"issue":"1S","key":"10.1016\/j.bulcan.2020.04.015_bib0385","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.bulcan.2019.07.011","article-title":"Haploidentical hematopoietic stem cell transplant: how to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"107","author":"Dubois","year":"2020","journal-title":"Bull Cancer (Paris)"},{"issue":"5","key":"10.1016\/j.bulcan.2020.04.015_bib0390","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/bmt.2015.351","article-title":"Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI","volume":"51","author":"Cluzeau","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bulcan.2020.04.015_bib0395","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbmt.2019.02.020","article-title":"Donor-specific Anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes","volume":"25","author":"Bramanti","year":"2019","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0400","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41409-018-0334-y","article-title":"Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders","volume":"54","author":"Woolfrey","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bulcan.2020.04.015_bib0405","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","article-title":"Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation","volume":"21","author":"Ciurea","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2020.04.015_bib0410","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bulcan.2020.04.015_bib0415","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.exphem.2012.06.003","article-title":"Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens","volume":"40","author":"Detrait","year":"2012","journal-title":"Exp Hematol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbmt.2015.09.027","article-title":"Donor immunization against human leukocyte class II antigens is a risk factor for graft-versus-host disease","volume":"22","author":"Delbos","year":"2016","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0425","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.12890","article-title":"Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation","volume":"166","author":"Fasano","year":"2014","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.bulcan.2020.04.015_bib0430","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/bmt.2012.28","article-title":"Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors","volume":"47","author":"Taniguchi","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bulcan.2020.04.015_bib0435","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humimm.2018.08.009","article-title":"The association of de novo anti-HLA-DPB1\u00a0donor-specific antibody formation and primary graft failure after allogeneic hematopoietic cell transplantation","volume":"79","author":"Hefazi","year":"2018","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0440","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bmt.2015.292","article-title":"Post-transplantation-emerging anti-HLA DQA1\/DQB1\u00a0antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting","volume":"51","author":"Yabe","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/vox.12085","article-title":"Human platelet antigens - 2013","volume":"106","author":"Curtis","year":"2014","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0450","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.bulcan.2020.04.015_bib0455","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/trf.14316","article-title":"How do I\u2026 manage the platelet transfusion-refractory patient?","volume":"57","author":"Juskewitch","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0460","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1423-0410.2005.00692.x","article-title":"Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report","volume":"89","author":"Macher","year":"2005","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0465","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.2007.06753.x","article-title":"Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay","volume":"139","author":"Arber","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0470","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1537-2995.2009.02448.x","article-title":"Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation","volume":"50","author":"Lucas","year":"2010","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0475","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tracli.2010.07.002","article-title":"Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1\u00a0allo-immunisation of the host","volume":"17","author":"Parissiadis","year":"2010","journal-title":"Transfus Clin Biol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0480","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1989.tb04264.x","article-title":"Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1\u00a0specificity: evidence for a host-derived immune reaction","volume":"71","author":"Panzer","year":"1989","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0485","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.1994.tb04801.x","article-title":"Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation","volume":"86","author":"Taaning","year":"1994","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.bulcan.2020.04.015_bib0490","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1704222","article-title":"Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning","volume":"32","author":"Leitner","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1537-2995.2004.04115.x","article-title":"The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen","volume":"45","author":"Leitner","year":"2005","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0500","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1423-0410.2007.01031.x","article-title":"Human neutrophil alloantigens","volume":"94","author":"Bux","year":"2008","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0505","first-page":"559","article-title":"Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT","volume":"18","author":"Klumpp","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0510","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0609.1999.tb01115.x","article-title":"Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation","volume":"62","author":"Tazzari","year":"1999","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0515","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.2001.02779.x","article-title":"Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factor","volume":"113","author":"Pocock","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0520","doi-asserted-by":"crossref","DOI":"10.1111\/tri.12243","article-title":"Neutropenia associated with antihuman neutrophil antibodies following allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Shingai","year":"2014","journal-title":"Transpl Int"},{"issue":"7","key":"10.1016\/j.bulcan.2020.04.015_bib0525","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26388","article-title":"Prolonged neutropenia due to antihuman neutrophil antigen 2 (CD177) antibody after bone marrow transplantation","volume":"64","author":"Wada","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.bulcan.2020.04.015_bib0530","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1537-2995.1998.38798346635.x","article-title":"Expression of neutrophil antigens after 10\u00a0days of granulocyte-colony-stimulating factor","volume":"38","author":"Stroncek","year":"1998","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0535","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1542\/peds.109.4.e64","article-title":"Resistance to recombinant human granulocyte colony-stimulating factor in neonatal alloimmune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies","volume":"109","author":"Maheshwari","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0540","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/trf.13878","article-title":"Evaluation of a new microbeads assay for granulocyte antibody detection","volume":"57","author":"Schulz","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"11","key":"10.1016\/j.bulcan.2020.04.015_bib0545","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3324\/haematol.12933","article-title":"Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program","volume":"93","author":"Kimura","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bulcan.2020.04.015_bib0550","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.exphem.2008.01.017","article-title":"Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"36","author":"Michallet","year":"2008","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0555","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbmt.2014.12.036","article-title":"ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation","volume":"21","author":"Logan","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0560","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bulcan.2020.04.015_bib0565","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajh.24771","article-title":"ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: a report from the acute leukemia working party of the EBMT","volume":"92","author":"Canaani","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.bulcan.2020.04.015_bib0570","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bulcan.2020.04.015_bib0575","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbmt.2017.02.009","article-title":"Donor-to-recipient ABO mismatch does not impact outcomes of allogeneic hematopoietic cell transplantation regardless of graft source","volume":"23","author":"Damodar","year":"2017","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0580","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2017.199","article-title":"Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants","volume":"32","author":"Wang","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bulcan.2020.04.015_bib0585","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41409-019-0496-2","article-title":"ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation","volume":"54","author":"Kimura","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2020.04.015_bib0590","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bmt.2011.135","article-title":"Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation","volume":"46","author":"Rowley","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000441507","article-title":"ABO-mismatched allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Worel","year":"2016","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0600","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","article-title":"Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors","volume":"147","author":"Rocha","year":"2009","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000206308","article-title":"Transplant of rhesus-positive bone marrow in a rhesus-negative woman having anti-rhesus D alloantibodies","volume":"73","author":"Rigal","year":"1985","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0610","first-page":"46","article-title":"Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia","volume":"71","author":"Girelli","year":"1986","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1537-2995.1988.28388219159.x","article-title":"Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation","volume":"28","author":"Heim","year":"1988","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0620","first-page":"632","article-title":"Anti-D antibody of exclusive IgM class after minor Rh(D)-mismatched BMT","volume":"16","author":"Esteve","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0625","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1537-2995.1998.38398222868.x","article-title":"Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant","volume":"38","author":"L\u00f3pez","year":"1998","journal-title":"Transfusion (Paris)"},{"issue":"10","key":"10.1016\/j.bulcan.2020.04.015_bib0630","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1701226","article-title":"Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT","volume":"21","author":"Franchini","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0635","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0955-3886(99)00020-X","article-title":"Multiple red blood cell antibodies produced by donor B lymphocytes after ABO-matched allogeneic bone marrow transplantation","volume":"20","author":"Tasaki","year":"1999","journal-title":"Transfus Sci"},{"issue":"4","key":"10.1016\/j.bulcan.2020.04.015_bib0640","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bmt.1702149","article-title":"Detection of an anti-RhD antibody 2\u00a0years after sensitization in a patient who had undergone an allogeneic BMT","volume":"25","author":"Gandini","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2020.04.015_bib0645","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1537-2995.2000.40060632.x","article-title":"Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation","volume":"40","author":"Leo","year":"2000","journal-title":"Transfusion (Paris)"},{"issue":"12","key":"10.1016\/j.bulcan.2020.04.015_bib0650","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bmt.1703074","article-title":"Immune hemolysis involving non-ABO\/RhD alloantibodies following hematopoietic stem cell transplantation","volume":"27","author":"Young","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0655","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1537-2995.2001.41010106.x","article-title":"Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?","volume":"41","author":"de La Rubia","year":"2001","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0660","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1537-2995.2003.00303.x","article-title":"Long-term production of pre-existing alloantibodies to E and c after allogenic BMT in a patient with aplastic anemia resulting in delayed hemolytic anemia","volume":"43","author":"Izumi","year":"2003","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.bulcan.2020.04.015_bib0665","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1537-2995.2005.04104.x","article-title":"Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation","volume":"45","author":"Zupa\u0144ska","year":"2005","journal-title":"Transfusion (Paris)"},{"issue":"3","key":"10.1016\/j.bulcan.2020.04.015_bib0670","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/bmt.2012.152","article-title":"Rh D alloimmunization in allogeneic HSCT","volume":"48","author":"Chan","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0675","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1537-2995.1987.27287150186.x","article-title":"Red cell alloantibodies produced after bone marrow transplantation","volume":"27","author":"Ting","year":"1987","journal-title":"Transfusion (Paris)"},{"issue":"11","key":"10.1016\/j.bulcan.2020.04.015_bib0680","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1537-2995.1995.351196110898.x","article-title":"Low incidence of red cell and HLA antibody formation by bone marrow transplant patients","volume":"35","author":"Abou-Elella","year":"1995","journal-title":"Transfusion (Paris)"},{"issue":"8","key":"10.1016\/j.bulcan.2020.04.015_bib0685","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1537-2995.2005.00214.x","article-title":"The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation","volume":"45","author":"Erker","year":"2005","journal-title":"Transfusion (Paris)"},{"issue":"6","key":"10.1016\/j.bulcan.2020.04.015_bib0690","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1537-2995.2011.03457.x","article-title":"Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning","volume":"52","author":"Worel","year":"2012","journal-title":"Transfusion (Paris)"},{"issue":"9","key":"10.1016\/j.bulcan.2020.04.015_bib0695","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0198-8859(00)00162-2","article-title":"Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients","volume":"61","author":"Zwirner","year":"2000","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0700","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00251-008-0344-9","article-title":"Polymorphisms of MICA recognized by human alloantibodies","volume":"61","author":"Zou","year":"2009","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.bulcan.2020.04.015_bib0705","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/TP.0b013e3181e228f7","article-title":"Major histocompatibility complex class 1\u00a0chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes","volume":"90","author":"Lemy","year":"2010","journal-title":"Transplantation"},{"issue":"13","key":"10.1016\/j.bulcan.2020.04.015_bib0710","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.bulcan.2020.04.015_bib0715","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1182\/blood-2009-04-217430","article-title":"MICA-129\u00a0genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease","volume":"114","author":"Boukouaci","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bulcan.2020.04.015_bib0720","doi-asserted-by":"crossref","first-page":"e72141","DOI":"10.1371\/journal.pone.0072141","article-title":"The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children","volume":"8","author":"Ansari","year":"2013","journal-title":"PloS One"},{"issue":"1S","key":"10.1016\/j.bulcan.2020.04.015_bib0725","article-title":"Transfusion in autologous and allogenic hematopoietic stem cell transplant: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"106","author":"Giraud","year":"2019","journal-title":"Bull Cancer (Paris)"},{"issue":"14","key":"10.1016\/j.bulcan.2020.04.015_bib0730","first-page":"1397","article-title":"Hemolytic transfusion reactions. Reply","volume":"381","author":"Panch","year":"2019","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.bulcan.2020.04.015_bib0735","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/blood-2009-05-223172","article-title":"Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease","volume":"114","author":"Parmar","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bulcan.2020.04.015_bib0370","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bbmt.2014.07.019","article-title":"Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1\u00a0mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation","volume":"20","author":"Askar","year":"2014","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120302587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120302587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:11Z","timestamp":1757791991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120302587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0007455120302587"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.04.015","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance des anticorps dans la prise en charge de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: anticorps anti-HLA, anti-plaquettes, anti-granuleux, anti-\u00e9rythrocytes et anti-MICA. Recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}